Skip to main content

Day: June 2, 2021

Chalice Brands Ltd. Announces OTC Ticker Symbol Change to “CHALF”

PORTLAND, Ore., June 02, 2021 (GLOBE NEWSWIRE) — Chalice Brands Ltd., formerly Golden Leaf Holdings Ltd., (CSE: CHAL) (OTCQB: CHALF) (“Chalice” or the “Company”), a premier consumer-driven cannabis company specializing in retail, production, processing, wholesale, and distribution, is pleased to announce a change in the Company’s stock symbol trading on the OTCQB® Venture Market (“OTCQB”). Effective June 3, 2021, the Company’s common shares will trade on the OTCQB under the symbol “CHALF”. The previous trading symbol was “GLDFF”. About Chalice Brands Ltd, formerly Golden Leaf Holdings Ltd. Chalice Brands is a premier consumer-driven cannabis company specializing in production, processing, wholesale, distribution and retail, with seven dispensaries in Portland, Oregon. The Company is committed...

Continue reading

Sorrento Completes Acquisition of ACEA Therapeutics, Creating a Major Oncology Franchise

AMONG MULTIPLE CLINICAL- AND PRECLINICAL-STAGE NCE (NEW CHEMICAL ENTITY) COMPOUNDS ACQUIRED, ABIVERTINIB IS AN ANCHORING LATE-STAGE DRUG PRODUCT WITH POSITIVE CLINICAL TRIAL RESULTS IN BOTH NON-SMALL CELL LUNG CANCER (NSCLC) AND B-CELL LYMPHOMA:Abivertinib is potentially one of the most effective clinical-stage dual tyrosine kinase inhibitors (TKI), targeting both mutant epidermal growth factor receptor (EGFR) and Bruton’s tyrosine kinase (BTK). Abivertinib is a pyrrolopyrimidine-based irreversible third-generation (3G) EGFR TKI, structurally distinct from all other 3G pyrimidine-based EGFR inhibitors. More than 600 cancer patients have been treated with Abivertinib with a strong safety profile. At the Recommended Phase 2 Dose (RP2D), 300 mg BID, Abivertinib demonstrated favorable clinical efficacy and manageable adverse events in...

Continue reading

Bassist and Producer Al Carty Leverages ClearOne Aura® Home Office Solution to Adapt to a Changing Music Industry

Touring veteran who supported Rob Thomas, Alicia Keys and Ed Sheeran says the events of 2020 prove that collaboration equipment is vital for artists to leverage new opportunitiesAl CartyBassist and ProducerAl Carty“Every gig you do is an interview for the next gig, and first impressions are as important as ever,” said Carty.SALT LAKE CITY, June 02, 2021 (GLOBE NEWSWIRE) — Before the world went into periodic lockdowns and work-from-home grew from a curiosity to a standard operating procedure, many people didn’t put a lot of thought into the quality of the cameras and microphones they use to present themselves digitally. For touring musician, producer and recording artist Al Carty, it became clear as the Covid-19 virus continued to wreak havoc on daily life that we may be experiencing a permanent...

Continue reading

PolyPid to Present at Upcoming Healthcare Investor Conferences

PETAH TIKVA, Israel, June 02, 2021 (GLOBE NEWSWIRE) — PolyPid Ltd. (Nasdaq: PYPD), a late-stage biopharma company aiming to improve surgical outcomes through locally administered, controlled, extended-release therapeutics, today announced that members of its executive management team will present at three upcoming healthcare investor conferences. Key presentation details include:The 2021 LD Micro Invitational XIDate: Thursday, June 10, 2021 Time: 10:30 a.m. ETThe JMP Securities Life Sciences ConferenceDate: Wednesday, June 16, 2021 Time: 10:30 a.m. ETThe Raymond James Human Health Innovation ConferenceDate: Monday, June 21, 2021 Time: 9:30 a.m. ETThe Raymond James Human Health Innovation Conference presentation will be webcast live and archived for 90 days on PolyPid’s Investor Relations website at https://investors.polypid.com/. About PolyPid PolyPid...

Continue reading

Ensemble Health Partners Acquires Digital Patient Communications Platform, Odeza, to Transform Patient Experience

Cincinnati, Ohio, June 02, 2021 (GLOBE NEWSWIRE) — Ensemble Health Partners (“Ensemble”), the industry leader in end-to-end revenue cycle management, announced today it has acquired Odeza, an all-in-one digital consumer communications platform that integrates with leading electronic health record (“EHR”) platforms to unify, simplify and automate patient interactions. The integration of this innovative technology into Ensemble’s proprietary revenue cycle platform, Ensemble IQ, will provide engaging digital experiences for patients while increasing revenues and reducing administrative costs for providers.  Odeza facilitates a uniquely integrated approach by bringing together the key elements of convenience and coordination frequently missing from traditional provider-patient communications. Using AI-enabled communication...

Continue reading

Guardion Health Sciences Broadens Clinical Nutrition Product Offerings by Closing Acquisition of Activ Nutritional, which owns the Science Backed, Revenue-Generating Viactiv® Product Line, from Adare Pharmaceuticals

Acquisition to Transform and Strengthen Guardion’s Clinical Nutrition Product Portfolio Guardion Will Continue to Explore Additional Growth Opportunities to Further Expand its Presence in the Clinical Nutrition Market SAN DIEGO, June 02, 2021 (GLOBE NEWSWIRE) — Guardion Health Sciences, Inc. (Nasdaq: GHSI) (“Guardion” or the “Company”), a clinical nutrition and diagnostics company that develops clinically supported nutrition, medical foods, supplements and medical devices, today announced the closing of the first acquisition in its strategy to more widely compete in the clinical nutrition market. The Company closed on the recently announced Equity Purchase Agreement with Adare Pharmaceuticals, Inc. (“Adare”) to acquire all of the equity of Activ Nutritional, LLC for a cash payment of $26 million, subject to certain adjustments....

Continue reading

Invesco Ltd.: Form 8.3 – Sanne Group Plc

FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE BYA PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”)1. KEY INFORMATION     (a) Full name of discloser: Invesco Ltd.  (b) Owner or controller of interests and short positions disclosed, if different from 1(a):The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.    (c) Name of offeror/offeree in relation to whose relevant securities this form relates:Use a separate form for each offeror/offeree Sanne Group PLC  (d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:    (e) Date position held/dealing undertaken:For an opening position disclosure, state the latest practicable date...

Continue reading

Building a better future together: Methanex releases SASB-aligned 2020 Sustainability Report

Methanex 2020 Sustainability ReportBuilding a better future together: Methanex releases SASB-aligned 2020 Sustainability ReportVANCOUVER, British Columbia, June 02, 2021 (GLOBE NEWSWIRE) — Methanex Corporation (TSX:MX) (NASDAQ:MEOH), the world’s largest producer and supplier of methanol, today released its 2020 Sustainability Report to share its progress on the material environmental, social and governance (ESG) topics of most importance to the company’s business and stakeholders. Methanex has reported on its sustainability performance since 1997 and this year’s report provides greater transparency and comparability by aligning its disclosures with the Sustainability Accounting Standards Board (SASB) standards and some elements of the Task Force on Climate-related Financial Disclosures (TCFD) and Global Reporting...

Continue reading

North American Construction Group Ltd. Announces Full Exercise of the Over-Allotment Option

NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR DISSEMINATION IN THE U.S. ACHESON, Alberta, June 02, 2021 (GLOBE NEWSWIRE) — North American Construction Group Ltd. (“NACG” or the “Company”) (TSX/NYSE: NOA) is pleased to announce that the Underwriters (as defined below) have exercised their over-allotment option (the “Over-Allotment Option”), in full, to purchase an additional $9.75 million aggregate principal amount of 5.50% convertible unsecured subordinated debentures of the Company (the “Debentures”), on the same terms and conditions of the Company’s recently completed offering of Debentures (the “Offering”), for aggregate gross proceeds to the Company of $74,750,000. The Offering was completed through a syndicate of underwriters led by National Bank Financial Inc. and including Canaccord Genuity Corp., CIBC World Markets...

Continue reading

6/2/21: Verizon declares quarterly dividend

BASKING RIDGE, N.J., June 02, 2021 (GLOBE NEWSWIRE) — The Board of Directors at Verizon Communications Inc. (NYSE, Nasdaq: VZ) today declared a quarterly dividend of 62.75 cents per outstanding share, consistent with the previous three quarters. The quarterly dividend is payable on August 2, 2021, to Verizon shareholders of record at the close of business on July 9, 2021. “We remain committed to delivering value to our shareholders as we continue to execute our multi-purpose network strategy and grow the top and bottom lines,” said Chairman and CEO Hans Vestberg. “With the strength of our business and revenue growth trajectory, we look forward to putting the Board in the position to raise the dividend again later this year, which we have done for 14 consecutive years.” Verizon has approximately 4.1 billion shares of common stock...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.